글로벌 항인지질 항체 증후군 시장 – 2029년까지의 산업 동향 및 예측

항인지질 항체 증후군 시장 분석 및 규모

글로벌 항인지질 항체 증후군 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 취약한 노령 인구와 약물에 대한 높은 수요는 항인지질 항체 증후군 시장 성장에 영향을 미치는 요인 중 일부입니다. 많은 주요 시장 참여자가 약물 발견 및 개발에 많은 기여를 하고 있습니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 항인지질 항체 증후군 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

시장 정의

항인지질 항체 증후군은 휴즈 증후군이라고도 불리며 재발성 동맥 또는 정맥 혈전증, 순환 항인지질 항체의 존재 및 임신 이환율을 특징으로 하는 희귀한 자가면역 질환입니다. 주로 여성에게 발견될 수 있으며 단일 질환으로 발생하거나 전신성 홍반 루푸스와 관련이 있을 수 있습니다. 이는 의료 분야에 매우 중요하므로 예측 기간 동안 크게 증가할 것으로 예상됩니다.

보고 범위 및 시장 세분화

Global Antiphospholipid Antibody Syndrome Market Dynamics

Drivers

• Rising Awareness For Disease Treatment

Rising awareness among patients and healthcare professionals for treating different types of antiphospholipid antibody syndrome and more and more usage of combination therapy are the driving factors expected to boost the demand for global antiphospholipid antibody syndrome market during the forecast period of 2022-2029.

• Increasing Prevalence of Antiphospholipid Antibody Syndrome

As per a study conducted by García et. al. in 2019, the annual estimated incidence rate of antiphospholipid antibody syndrome was 50 per 100,000 population. In addition to this, as per the study conducted by D'Cruz et. al. in 2019, incidence of the syndrome in the U.K. rise high at 50 in females in 2011 and 9.8 per 100,000 in males in 2012. This boosts the market growth.

Opportunities

• Increasing Demand for Retail Pharmacies

The rise in the number of antiphospholipid antibody syndrome therapeutics being delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global antiphospholipid antibody syndrome market over a forecast period.

• High Cost

The huge expenditure of the treatment methods surely hamper the market growth.

This global antiphospholipid antibody syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global antiphospholipid antibody syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Antiphospholipid Antibody Syndrome Market

The covid-19 pandemic negatively impacted the global antiphospholipid antibody syndrome market because the utmost priority was given to Covid-19 patients for treatment. Several medical colleges and hospitals were reorganised and helped in the structure so that they can accommodate more patients diagnosed with Covid-19. Discovery and development of drugs for the types of metabolic syndromes also slowed down during the pandemic, but surely it wasn’t in a pause and now in the post pandemic era, it is rising again.

Global Antiphospholipid Antibody Syndrome Market Scope

The global antiphospholipid antibody syndrome market is segmented on the basis of disease type, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Anticoagulants
• NSAIDS
• Others

Route of Administration

• Oral
• Parental
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Antiphospholipid Antibody Syndrome Market Regional Analysis/Insights

The global antiphospholipid antibody syndrome market is analysed and market size insights and trends are provided by disease type, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global antiphospholipid antibody syndrome market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of refined healthcare expenditure and increased patient awareness level.

Asia-Pacific dominates the market due to the availability of broad range of therapeutics and favourable regulatory guidelines

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Antiphospholipid Antibody Syndrome Market Share Analysis

글로벌 항인지질 항체 증후군 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 항인지질 항체 증후군 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 항인지질 항체 증후군 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 노바티스 AG(스위스)
• Fresenius Kabi AG(독일)
• 아콘 주식회사(미국)
• 마일런 NV(미국)
• 존슨앤존슨 서비스 주식회사(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 릴리(미국)
• 머크앤코(미국)
• Aurobindo Pharma(인도)
• 심천테크다우제약(주)(중국)
• Bayer AG(독일)
• Teva Pharmaceuticals Industries Ltd. (이스라엘)
• 릴리(미국)
• 아스트라제네카(영국)

SKU-53904